Fingerprint
Dive into the research topics of 'Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
Jingyu Xiang, Mijia Lu, Min Shi, Xiaogang Cheng, Kristin A. Kwakwa, Jennifer L. Davis, Xinming Su, Suzanne J. Bakewell, Yuexiu Zhang, Francesca Fontana, Yalin Xu, Deborah J. Veis, John F. DiPersio, Lee Ratner, Ralph D. Sanderson, Alessandro Noseda, Shamim Mollah, Jianrong Li, Katherine N. Weilbaecher
- Division of Oncology
- Section of Molecular Oncology & Developmental Therapeutics
- Division of Cardiology
- Institute of Clinical and Translational Sciences (ICTS)
- Division of Bone & Mineral Diseases
- Center of Regenerative Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Rheumatic Diseases Research Resource-Based Center
- Siteman Cancer Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Department of Genetics
- Institute for Informatics, Data Science and Biostatistics (I2DB)
- DBBS - Molecular Cell Biology
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- DBBS - Computational and Systems Biology
- DBBS - Biomedical Informatics and Data Science
- Section of Bone Marrow Transplant & Leukemia
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations